# FDA Inspection 971682 - Daiichi Sankyo Chemical Pharma Co., Ltd. - April 15, 2016

Source: https://www.keypedia.com/records/fda_inspections/daiichi-sankyo-chemical-pharma-co-ltd/73fd6ff7-ff1d-48e4-9fb1-8898fb9450d1
Source feed: FDA_Inspections

> FDA Inspection 971682 for Daiichi Sankyo Chemical Pharma Co., Ltd. on April 15, 2016. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 971682
- Company Name: Daiichi Sankyo Chemical Pharma Co., Ltd.
- Inspection Date: 2016-04-15
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1081871 - 2019-01-25](https://www.keypedia.com/records/fda_inspections/daiichi-sankyo-chemical-pharma-co-ltd/59630dec-a3a1-4c89-a348-2502b37755dc)
- [FDA Inspection 891670 - 2014-06-20](https://www.keypedia.com/records/fda_inspections/daiichi-sankyo-chemical-pharma-co-ltd/63317e84-2089-4089-85bb-29f8a5f3353e)

Company: https://www.keypedia.com/companies/daiichi-sankyo-chemical-pharma-co-ltd/83cd6ae3-96fe-46bb-85a7-2aee947e573b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c